LBRX CIK: 1691082

LB Pharmaceuticals Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY24
FY25
FY24 – FY25

Assets

(positive)
Change from FY24 to FY25
millions USD
FY24:
28.9
FY25:
308
(positive)
Change from FY24 to FY25
millions USD
FY24:
4.66
FY25:
4.50
Total assets
Change from FY24 to FY25
millions USD
FY24:
33.5
FY25:
313

Liabilities & Equity

(negative)
Change from FY24 to FY25
millions USD
FY24:
8.11
FY25:
7.44
(negative)
Change from FY24 to FY25
millions USD
FY24:
5.72
FY25:
4.18
(positive)
Change from FY24 to FY25
millions USD
FY24:
−94.6
FY25:
301
Total liabilities & equity
millions USD
FY24:
–
FY25:
313

All amounts in millions USD Data source:SEC EDGAR